Allo-HLA reactivity of virus-specific memory T cells is common

Avital L. Amir(Leiden University Medical Center), Lloyd D’Orsogna(Leiden University Medical Center), Dave L. Roelen(Leiden University Medical Center), Marleen M. van Loenen(Leiden University Medical Center), Renate S. Hagedoorn(Leiden University Medical Center), Renate de Boer(Leiden University Medical Center), Menno A. W. G. van der Hoorn(Leiden University Medical Center), Michel G.D. Kester(Leiden University Medical Center), Ilias I.N. Doxiadis(Leiden University Medical Center), J.H. Frederik Falkenburg(Leiden University Medical Center), Frans H.J. Claas(Leiden University Medical Center), Mirjam H.M. Heemskerk(Leiden University Medical Center)
Blood
February 17, 2010
Cited by 291Open Access
Full Text

Abstract

Graft-versus-host disease and graft rejection are major complications of allogeneic HLA-mismatched stem cell transplantation or organ transplantation that are caused by alloreactive T cells. Because a range of acute viral infections have been linked to initiating these complications, we hypothesized that the cross-reactive potential of virus-specific memory T cells to allogeneic (allo) HLA molecules may be able to mediate these complications. To analyze the allo-HLA reactivity, T cells specific for Epstein-Barr virus, cytomegalovirus, varicella zoster virus, and influenza virus were tested against a panel of HLA-typed target cells, and target cells transduced with single HLA molecules. Eighty percent of T-cell lines and 45% of virus-specific T-cell clones were shown to cross-react against allo-HLA molecules. The cross-reactivity of the CD8 and CD4 T-cell clones was directed primarily against HLA class I and II, respectively. However, a restricted number of CD8 T cells exhibited cross-reactivity to HLA class II. T-cell receptor (TCR) gene transfer confirmed that allo-HLA reactivity and virus specificity were mediated via the same TCR. These results demonstrate that a substantial proportion of virus-specific T cells exert allo-HLA reactivity, which may have important clinical implications in transplantation settings as well as adoptive transfer of third-party virus-specific T cells.


Related Papers

No related papers found

Powered by citation graph analysis